Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Global Monochloroacetic Acid (MCAA) Market 2015-2019
Publication Date Jun 2015
Product Type Report
Pages 83
Single User License help $ 3000.00
Site User License help $ 3500.00
Corporate User License help $ 4500.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

About MCAA

MCAA, also called chloroacetic acid, is a bi-functional molecule-structured acid. It is extensively used as a chemical intermediate for the production of numerous industrially and commercially important chemicals, including glycine, CMC, TGA, and cyanoacetic acid. It is also used in the production of betaine-type surfactants, synthetic caffeine, and vitamins, and the production of 2,4-D and methanoates for using in herbicides. MCAA is commercially produced through the chlorination of acetic acid during the production of acetic anhydride as a catalyst.

Technavio's analysts forecast the global MCAA market to grow at a CAGR of 3.84% over the period 2015-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of the global MCAA market for the period 2015-2019. It provides data on the market based on the following:
• Application (glycine, CMC, surfactants, TGA, and 2,4-D and others)
• Geography (APAC, North America, ROW, and Western Europe)

Technavio's report, Global MCAA Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. In addition, the report discusses the major drivers influencing the market growth, outlines the challenges faced by vendors and the market as a whole, and identifies the key emerging trends in the market.

Key Regions
• APAC
• North America
• ROW
• Western Europe       

Key Vendors
• AkzoNobel
• CABB
• Daicel
• Dow Chemical
• MCAA
• Niacet

Other Prominent Vendors
• Abblis Chemicals
• Alfa Aesar
• AOKChem
• Celanese
• ChemPacific
• Clariant
• Denak
• Finetech
• GFS Chemicals
• Hebei Donghua Chemical Group
• Letopharm
• Merck Millipore
• Meridian Chem Bond
• Reagents
• Shandong Huayang Science and Technology
• Shijiazhuang Hengyi Chemical
• Sigma-Aldrich
• Tractus
• Vitas-M
• Zylexa Pharma

Market Driver
• Growth of Global CMC Market
• For a full, detailed list, view our report

Market Challenge
• Issues in Availability of Raw Materials
• For a full, detailed list, view our report

Market Trend
• Increased Production of Cyanoacetic Acid
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space and what is their portfolio matrix?
• What are the market opportunities and threats faced by the key vendors?
• What is the competitive landscape as characterized by geography?
• What are the strengths and weaknesses of the key vendors?

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

07. Global MCAA Market

07.1 Market Size and Forecast by Revenue

07.2 Five Forces Analysis

08. Market Segmentation by Application

08.1 Segmentation of Global MCAA Market by Application 2014-2019

08.2 Global MCAA Market for Glycine

08.2.1 Market Size and Forecast

08.3 Global MCAA Market for CMC

08.3.1 Market Size and Forecast

08.4 Global MCAA Market for Surfactants

08.4.1 Market Size and Forecast

08.5 Global MCAA Market for TGA

08.5.1 Market Size and Forecast

08.6 Global MCAA Market for 2,4-D and Others

08.6.1 Market Size and Forecast

09. Geographical Segmentation

09.1 Segmentation of Global MCAA Market by Geography 2014-2019

09.2 MCAA Market in APAC

09.2.1 Market size and forecast

09.3 MCAA Market in Western Europe

09.3.1 Market Size and Forecast

09.4 MCAA Market in North America

09.4.1 Market Size and Forecast

09.5 MCAA Market in ROW

09.5.1 Market Size and Forecast

10. Key Leading Countries

10.1 MCAA Market in China

10.1.1 Market size and forecast

10.2 MCAA Market in India

10.2.1 Market size and forecast

10.3 MCAA Market in Germany

10.3.1 Market size and forecast

10.4 MCAA Market in US

10.4.1 Market size and forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

18.1 Competitive scenario

18.2 Major Vendor Analysis 2014

18.3 Other prominent vendors

19. Key Vendor Analysis

19.1 AkzoNobel

19.1.1 Key Facts

19.1.2 Business Overview

19.1.3 AkzoNobel: Business Segmentation by Revenue 2013

19.1.4 Business Segmentation by Revenue 2012 and 2013

19.1.5 Geographical Segmentation by Revenue 2013

19.1.6 Business Strategy

19.1.7 Recent Developments

19.1.8 SWOT Analysis

19.2 CABB

19.2.1 Key Facts

19.2.2 Business Overview

19.2.3 Geographical Presence

19.2.4 Recent Developments

19.2.5 SWOT Analysis

19.3 Daicel

19.3.1 Key Facts

19.3.2 Business Overview

19.3.3 Business Segmentation

19.3.4 Business Segmentation by Revenue 2013 and 2014

19.3.5 Geographical Segmentation by Revenue 2014

19.3.6 Recent Developments

19.3.7 SWOT Analysis

19.4 MCAA SE

19.4.1 Key Facts

19.4.2 Business Overview

19.4.3 Recent Developments

19.4.4 SWOT Analysis

19.5 Niacet

19.5.1 Key Facts

19.5.2 Business Overview

19.5.3 Product Segmentation

19.5.4 Recent Developments

19.5.5 SWOT Analysis

19.6 Dow

19.6.1 Key Facts

19.6.2 Business Overview

19.6.3 Business Segmentation by Revenue 2013

19.6.4 Business Segmentation by Revenue 2012 and 2013

19.6.5 Geographical Segmentation by Revenue 2013

19.6.6 Business Strategy

19.6.7 Recent Developments

19.6.8 SWOT Analysis

20. Other Reports in this Series


List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Segmentation of Global MCAA Market
Exhibit 3: Segmentation of Global MCAA Market by Application
Exhibit 4: Segmentation of Global MCAA Market by Geography
Exhibit 5: Global MCAA Market 2014-2019 ($ millions)
Exhibit 6: Segmentation of Global MCAA Market by Application 2014 and 2019
Exhibit 7: Segmentation of Global MCAA Market by Application 2014-2019 ($ millions)
Exhibit 8: Global MCAA Market for Glycine 2014-2019 ($ millions)
Exhibit 9: Global MCAA Market for CMC 2014-2019 ($ millions)
Exhibit 10: Global MCAA Market for Surfactants 2014-2019 ($ millions)
Exhibit 11: Global MCAA Market for TGA 2014-2019 ($ millions)
Exhibit 12: Global MCAA Market for 2,4-D and Others 2014-2019 ($ millions)
Exhibit 13: Segmentation of Global MCAA Market by Geography 2014 and 2019
Exhibit 14: Segmentation of Global MCAA Market by Geography 2014-2019 ($ millions)
Exhibit 15: MCAA Market in APAC 2014-2019 ($ millions)
Exhibit 16: MCAA Market in Western Europe 2014-2019 ($ millions)
Exhibit 17: MCAA Market in North America 2014-2019 ($ millions)
Exhibit 18: MCAA Market in ROW 2014-2019 ($ millions)
Exhibit 19: MCAA Market in China 2014-2019 ($ millions)
Exhibit 20: MCAA Market in India 2014-2019 ($ millions)
Exhibit 21: MCAA Market in Germany 2014-2019 ($ millions)
Exhibit 22: MCAA Market in US 2014-2019 ($ millions)
Exhibit 23: Global CMC Market 2014-2019 ($ millions)
Exhibit 24: China: GDP growth rate 2011-2020 ($ trillions)
Exhibit 25: Value Addition in Chinese Construction Industry ($ billions)
Exhibit 26: Average Contract Price of Methanol in Asia and Europe 2014 ($/Metric Ton)
Exhibit 27: Growth of European Construction Industry (2007-2016)
Exhibit 28: Proposed Acetic Acid Capacity Additions in India
Exhibit 29: Global PVC Market 2014-2019 ($ billions)
Exhibit 30: Major Vendors in Global MCAA Market 2014
Exhibit 31: AkzoNobel: Business Segmentation by Revenue 2013
Exhibit 32: AkzoNobel: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 33: AkzoNobel: Geographical Segmentation by Revenue 2013
Exhibit 34: CABB: Geographical Presence
Exhibit 35: Daicel: Business Segmentation 2014
Exhibit 36: Daicel: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 37: Daicel: Geographical Segmentation by Revenue 2014
Exhibit 38: Niacet: Product Segmentation 2013
Exhibit 39: Dow: Business Segmentation by Revenue 2013
Exhibit 40: Dow: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 41: Dow: Geographical Segmentation by Revenue 2013

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
Global Dental Laboratory Handpieces Consumption 2016 Market Research Report
By QYResearch
The Global Dental Laboratory Handpieces Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Dental Laboratory Handpieces market. First, the report ...Read More
Jan 2016 $4000.00
Back to Report Store Home Cardiovascular Disorders Drug Development Pipeline Review, 2017
By GBI Research
Description Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dys ...Read More
Mar 2017 $3995.00
Back to Report Store Home Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
By GBI Research
Pain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain ...Read More
Aug 2016 $6995.00
Back to Report Store Home Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation
By GBI Research
Description Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 distinct dermatological conditions are thought to exist, ranging from rare a ...Read More
Jun 2017 $6995.00
Back to Report Store Home Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
By GBI Research
The hematological disorders therapy area encompasses non-malignant disorders of the blood such as anemia, sickle cell disease, neutropenia and hemophilia. These diseases can be grouped into the three ...Read More
Aug 2017 $6995.00
Back to Report Store Home Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
By GBI Research
Description Globally, liver cancer is the sixth most common cancer, but its poor prognosis makes it the second leading cause of cancer-related death (Globocan, 2012). Currently, the range of therapi ...Read More
Jun 2017 $6995.00
Back to Report Store Home Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
By GBI Research
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs when a ...Read More
Aug 2016 $6995.00
Back to Report Store Home Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential
By GBI Research
Immunology is a large therapy area characterized by disorders of the immune system – specifically an aberrant immune response against healthy tissues present in the body, leading to chronic or a ...Read More
Jan 2017 $6995.00
Back to Report Store Home Global Immunology Drugs Market to 2022-Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth
By GBI Research
Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response against healthy tissues in the body, leading to chronic or acute inflammation ...Read More
May 2017 $4995.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  Infiniti Research Ltd

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z